FDA Says Use of NSAIDs During Pregnancy Can Lead to Kidney Problems in Fetus




WASHINGTON, D.C. — The Food and Drug Administration has issued a warning that the use of nonsteroidal anti-inflammatory drugs around 20 weeks or later in pregnancy may cause rare but serious kidney problems in an unborn baby, leading to low levels of amniotic fluid.

In an Oct. 15 Drug Safety Communication, the agency says it is requiring changes to the labeling for prescription NSAIDs to reflect the risk of impaired renal function and oligohydramnios (too little amniotic fluid around your baby during pregnancy).

“For over the counter NSAIDs intended for use in adults, FDA will also update the Drug Facts …






UPCOMING CONFERENCES




HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

April 08, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS



HarrisMartin's MDL Conference: Depo-Provera and Current MDL Cases

January 29, 2025 - Miami Beach, FL
The Coral Ballroom at the Fontainebleau Miami Beach

MORE DETAILS